Use of an oxytocin antagonist in in vitro fertilization-embryo transfer for women with repeated implantation failure: A retrospective study

Taiwanese Journal of Obstetrics and Gynecology

Volumn 50, Issue 2, 2011, Pages 136-140

  Chou, Pei Yi ^a   Wu, Meng Hsing ^a   Pan, Hsien An ^a   Hung, Kuei Hsiang ^a   Chang, Fong Ming ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Clinical pregnancy rate; Embryo transfer; Implantation rate; Live birth rate; Oxytocin antagonist; Repeated implantation failure

Indexed keywords

ATOSIBAN; CETRORELIX; CHORIONIC GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN;

ABDOMINAL DISCOMFORT; ADULT; ARTICLE; BIRTH RATE; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SAFETY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE BLOOD LEVEL; HUMAN; HUMAN CELL; LIVE BIRTH; LUTEAL PHASE; MAJOR CLINICAL STUDY; MULTIPLE PREGNANCY; NAUSEA; NIDATION; OOCYTE RETRIEVAL; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY DISORDER; PREGNANCY OUTCOME; PREGNANCY RATE; REPEATED IMPLANTATION FAILURE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; UNSPECIFIED SIDE EFFECT;

ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; FERTILIZATION IN VITRO; HORMONE ANTAGONISTS; HUMANS; LIVE BIRTH; MALE; OXYTOCIN; PREGNANCY; PREGNANCY RATE; RECURRENCE; RETROSPECTIVE STUDIES; TREATMENT FAILURE; VASOTOCIN;

EID: 79960646292     PISSN: 10284559     EISSN: 18756263     Source Type: Journal    
DOI: 10.1016/j.tjog.2011.04.003     Document Type: Article

References (23)

1. Verhaak C.M., Smeenk J.M., Evers A.W., Kremer J.A., Kraaimaat F.W., Braat D.D. Women's emotional adjustment to IVF: a systematic review of 25 years of research. Hum Reprod Update 2007, 13:27-36.
2. Tan B.K., Vandekerckhove P., Kennedy R., Keay S.D. Investigation and current management of recurrent IVF treatment failure in the UK. BJOG 2005, 112:773-780.
3. Koler M., Achache H., Tsafrir A., Smith Y., Revel A., Reich R. Disrupted gene pattern in patients with repeated in vitro fertilization (IVF) failure. Hum Reprod 2009, 24:2541-2548.
4. Margalioth E.J., Ben-Chetrit A., Gal M., Eldar-Geva T. Investigation and treatment of repeated implantation failure following IVF-ET. Hum Reprod 2006, 21:3036-3043.
5. Maggi M., Del Carlo P., Fantoni G., Giannini S., Torrisi C., Casparis D., et al. Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors. J Clin Endocrinol Metab 1990, 70:1142-1154.
6. Bossmar T., Akerlund M., Fantoni G., Szamatowicz J., Melin P., Maggi M. Receptors for and myometrial responses to oxytocin and vasopressin in preterm and term human pregnancy: effects of the oxytocin antagonist atosiban. Am J Obstet Gynecol 1994, 171:1634-1642.
7. de Heus R., Mulder E.J., Derks J.B., Kurver P.H., van Wolfswinkel L., Visser G.H. A prospective randomized trial of acute tocolysis in term labour with atosiban or ritodrine. Eur J Obstet Gynecol Reprod Biol 2008, 139:139-145.
8. Akerlund M., Melin P., Maggi M. Potential use of oxytocin and vasopressin V1a antagonists in the treatment of preterm labour and primary dysmenorrhoea. Adv Exp Med Biol 1995, 395:595-600.
9. Pierzynski P., Reinheimer T.M., Kuczynski W. Oxytocin antagonists may improve infertility treatment. Fertil Steril 2007, 88:213.e19-213.e22.
10. Liang Y.L., Kuo T.C., Hung K.H., Chen T.H., Wu M.H. Oxytocin antagonist for repeated implantation failure and delay of delivery. Taiwan J Obstet Gynecol 2009, 48:314-316.
11. Moraloglu O., Tonguc E., Var T., Zeyrek T., Batioglu S. Treatment with oxytocin antagonists before embryo transfer may increase implantation rates after IVF. Reprod Biomed Online 2010, 21:338-343.
12. Johnston-MacAnanny E.B., Hartnett J., Engmann L.L., Nulsen J.C., Sanders M.M., Benadiva C.A. Chronic endometritis is a frequent finding in women with recurrent implantation failure after in vitro fertilization. Fertil Steril 2010, 93:437-441.
13. Fanchin R., Ayoubi J.M. Uterine dynamics: impact on the human reproduction process. Reprod Biomed Online 2009, 18(Suppl. 2):57-62.
14. Field T., Diego M., Hernandez-Reif M. Prematurity and potential predictors. Int J Neurosci 2008, 118:277-289.
15. Chen T.H., Chang S.P., Tsai C.F., Juang K.D. Prevalence of depressive and anxiety disorders in an assisted reproductive technique clinic. Hum Reprod 2004, 19:2313-2318.
16. Boivin J., Schmidt L. Infertility-related stress in men and women predicts treatment outcome 1 year later. Fertil Steril 2005, 83:1745-1752.
17. Wu M.Y., Chen S.U., Lee C.N., Ho H.N., Yang Y.S. Use of atosiban in a twin pregnancy with extremely preterm premature rupture in the membrane of one twin: a case report and literature review. Taiwan J Obstet Gynecol 2010, 49:495-499.
18. Furuya K., Mizumoto Y., Makimura N., Mitsui C., Murakami M., Tokuoka S., et al. A novel biological aspect of ovarian oxytocin: gene expression of oxytocin and oxytocin receptor in cumulus/luteal cells and the effect of oxytocin on embryogenesis in fertilized oocytes. Adv Exp Med Biol 1995, 395:523-528.
19. Beretsos P., Loutradis D., Koussoulakos S., Margaritis L.H., Kiapekou E., Mastorakos G., et al. Oxytocin receptor is differentially expressed in mouse endometrium and embryo during blastocyst implantation. Ann N Y Acad Sci 2006, 1092:466-479.
20. Bah M.M., Acosta T.J., Pilawski W., Deptula K., Okuda K., Skarzynski D.J. Role of intraluteal prostaglandin F(2alpha), progesterone and oxytocin in basal and pulsatile progesterone release from developing bovine corpus luteum. Prostaglandins Other Lipid Mediat 2006, 79:218-229.
21. Evans J.J., Reid R.A., Wakeman S.A., Croft L.B., Benny P.S. Evidence that oxytocin is a physiological component of LH regulation in non-pregnant women. Hum Reprod 2003, 18:1428-1431.
22. Goodwin T.M., Millar L., North L., Abrams L.S., Weglein R.C., Holland M.L. The pharmacokinetics of the oxytocin antagonist atosiban in pregnant women with preterm uterine contractions. Am J Obstet Gynecol 1995, 173:913-917.
23. Pierzynski P., Gajda B., Smorag Z., Rasmussen A.D., Kuczynski W. Effect of atosiban on rabbit embryo development and human sperm motility. Fertil Steril 2007, 87:1147-1152.